Paul Quinlan

Insider Reports History

Entity
Individual
Location
C/O Cymabay Therapeutics, Inc., 7575 Gateway Blvd., Suite 110, Newark, CA
Signature
/s/ Paul Quinlan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Paul Quinlan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CymaBay Therapeutics, Inc. General Counsel Common Stock 0 $0 $2.94 Mar 22, 2024 Direct
CymaBay Therapeutics, Inc. General Counsel Employee Stock Option (right to buy) 0 Mar 22, 2024 Direct

Insider Reports Filed by Paul Quinlan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ORKA Oruka Therapeutics, Inc. Aug 29, 2024 0 $0 3 Sep 6, 2024 General Counsel and Secretary
CBAY CymaBay Therapeutics, Inc. Mar 22, 2024 7 $0 4 Mar 22, 2024 General Counsel
CBAY CymaBay Therapeutics, Inc. Mar 13, 2024 2 $330K 4 Mar 15, 2024 General Counsel
CBAY CymaBay Therapeutics, Inc. Jan 24, 2024 2 $0 4 Jan 26, 2024 General Counsel
CBAY CymaBay Therapeutics, Inc. Jan 16, 2024 3 -$103K 4 Jan 16, 2024 General Counsel
CBAY CymaBay Therapeutics, Inc. Dec 15, 2023 3 -$95.2K 4 Dec 15, 2023 General Counsel
CBAY CymaBay Therapeutics, Inc. Nov 15, 2023 3 -$72.2K 4 Nov 17, 2023 General Counsel
CBAY CymaBay Therapeutics, Inc. Oct 16, 2023 3 -$54.1K 4 Oct 18, 2023 General Counsel
CBAY CymaBay Therapeutics, Inc. Sep 15, 2023 7 -$738K 4 Sep 19, 2023 General Counsel
CBAY CymaBay Therapeutics, Inc. Aug 15, 2023 3 -$44.9K 4 Aug 16, 2023 General Counsel
CBAY CymaBay Therapeutics, Inc. Jul 14, 2023 3 -$44.4K 4 Jul 14, 2023 General Counsel
CBAY CymaBay Therapeutics, Inc. Jun 30, 2023 3 -$35.6K 4 Jun 30, 2023 General Counsel
CBAY CymaBay Therapeutics, Inc. May 15, 2023 3 -$37.1K 4 May 17, 2023 General Counsel
CBAY CymaBay Therapeutics, Inc. Jan 25, 2023 1 $0 4 Jan 27, 2023 General Counsel
CBAY CymaBay Therapeutics, Inc. Jan 25, 2022 1 $0 4 Jan 27, 2022 General Counsel